Concepts (115)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Education, Pharmacy | 5 | 2024 | 124 | 2.400 |
Why?
|
| Pharmacists | 9 | 2019 | 74 | 1.880 |
Why?
|
| Community Pharmacy Services | 5 | 2017 | 22 | 1.710 |
Why?
|
| Pharmacy | 4 | 2022 | 36 | 1.610 |
Why?
|
| Pharmaceutical Services | 5 | 2019 | 41 | 1.330 |
Why?
|
| Medication Therapy Management | 5 | 2015 | 20 | 1.240 |
Why?
|
| Students, Pharmacy | 2 | 2024 | 91 | 1.030 |
Why?
|
| Diabetes Mellitus | 4 | 2024 | 215 | 1.020 |
Why?
|
| Problem-Based Learning | 1 | 2024 | 62 | 0.810 |
Why?
|
| Public Health | 1 | 2024 | 97 | 0.790 |
Why?
|
| Hypoglycemic Agents | 2 | 2017 | 110 | 0.760 |
Why?
|
| Program Evaluation | 3 | 2015 | 176 | 0.630 |
Why?
|
| Checklist | 1 | 2019 | 22 | 0.600 |
Why?
|
| Antihypertensive Agents | 2 | 2017 | 56 | 0.580 |
Why?
|
| Delivery of Health Care, Integrated | 2 | 2015 | 16 | 0.560 |
Why?
|
| Hepatitis B Vaccines | 1 | 2017 | 4 | 0.510 |
Why?
|
| Medication Adherence | 1 | 2017 | 48 | 0.500 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 77 | 0.500 |
Why?
|
| Surveys and Questionnaires | 5 | 2024 | 1011 | 0.480 |
Why?
|
| Patient-Centered Care | 1 | 2015 | 38 | 0.450 |
Why?
|
| Curriculum | 3 | 2024 | 307 | 0.450 |
Why?
|
| Vaccination | 1 | 2017 | 213 | 0.450 |
Why?
|
| Health Services Accessibility | 1 | 2015 | 121 | 0.420 |
Why?
|
| Humans | 21 | 2026 | 28998 | 0.420 |
Why?
|
| Professional Role | 5 | 2015 | 46 | 0.390 |
Why?
|
| Managed Care Programs | 1 | 2012 | 16 | 0.360 |
Why?
|
| Community Health Services | 1 | 2012 | 34 | 0.360 |
Why?
|
| Male | 11 | 2026 | 13983 | 0.350 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2024 | 310 | 0.340 |
Why?
|
| Disease Management | 1 | 2012 | 91 | 0.340 |
Why?
|
| Female | 10 | 2024 | 15690 | 0.310 |
Why?
|
| Adult | 9 | 2026 | 8048 | 0.310 |
Why?
|
| Models, Organizational | 1 | 2008 | 18 | 0.290 |
Why?
|
| Patient Compliance | 1 | 2009 | 77 | 0.290 |
Why?
|
| Quality of Health Care | 1 | 2009 | 84 | 0.280 |
Why?
|
| Aged, 80 and over | 5 | 2026 | 2067 | 0.280 |
Why?
|
| Research | 1 | 2008 | 93 | 0.270 |
Why?
|
| Middle Aged | 8 | 2026 | 7428 | 0.270 |
Why?
|
| Aged | 8 | 2026 | 5608 | 0.270 |
Why?
|
| Educational Measurement | 2 | 2024 | 139 | 0.260 |
Why?
|
| Communication | 1 | 2008 | 184 | 0.240 |
Why?
|
| Social Responsibility | 1 | 2004 | 11 | 0.220 |
Why?
|
| Drug Therapy | 1 | 2004 | 15 | 0.220 |
Why?
|
| Cancer Survivors | 1 | 2026 | 72 | 0.220 |
Why?
|
| Hearing Loss | 1 | 2024 | 39 | 0.200 |
Why?
|
| Health Policy | 1 | 2024 | 63 | 0.200 |
Why?
|
| Cooperative Behavior | 2 | 2015 | 78 | 0.200 |
Why?
|
| Prostatic Neoplasms | 1 | 2026 | 302 | 0.190 |
Why?
|
| Treatment Outcome | 2 | 2009 | 2427 | 0.190 |
Why?
|
| Psychometrics | 1 | 2022 | 122 | 0.180 |
Why?
|
| Quality of Life | 1 | 2026 | 523 | 0.180 |
Why?
|
| Health Status | 1 | 2002 | 149 | 0.180 |
Why?
|
| Pandemics | 1 | 2022 | 205 | 0.170 |
Why?
|
| Depression | 1 | 2002 | 227 | 0.160 |
Why?
|
| Health Literacy | 1 | 2020 | 34 | 0.160 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 788 | 0.160 |
Why?
|
| Patient Care | 1 | 2019 | 14 | 0.150 |
Why?
|
| Research Report | 1 | 2019 | 23 | 0.150 |
Why?
|
| Advisory Committees | 1 | 2019 | 33 | 0.150 |
Why?
|
| Health Care Surveys | 2 | 2012 | 69 | 0.140 |
Why?
|
| Young Adult | 2 | 2024 | 2842 | 0.140 |
Why?
|
| Diabetes Complications | 2 | 2024 | 66 | 0.140 |
Why?
|
| Cross-Sectional Studies | 5 | 2024 | 1004 | 0.140 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 249 | 0.140 |
Why?
|
| Hypertension | 2 | 2012 | 309 | 0.130 |
Why?
|
| Appointments and Schedules | 1 | 2017 | 10 | 0.130 |
Why?
|
| Midwestern United States | 1 | 2017 | 40 | 0.130 |
Why?
|
| Hepatitis B | 1 | 2017 | 14 | 0.130 |
Why?
|
| Ambulatory Care Facilities | 1 | 2017 | 55 | 0.120 |
Why?
|
| Internship and Residency | 2 | 2017 | 263 | 0.120 |
Why?
|
| Interviews as Topic | 2 | 2008 | 162 | 0.120 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2015 | 10 | 0.120 |
Why?
|
| Interdisciplinary Communication | 1 | 2015 | 19 | 0.120 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2017 | 104 | 0.120 |
Why?
|
| Health Care Costs | 1 | 2015 | 51 | 0.120 |
Why?
|
| Medication Errors | 1 | 2015 | 26 | 0.110 |
Why?
|
| Aging | 1 | 2002 | 1019 | 0.110 |
Why?
|
| Family Practice | 1 | 2015 | 47 | 0.110 |
Why?
|
| Medical Waste Disposal | 1 | 2014 | 1 | 0.110 |
Why?
|
| Patient Participation | 1 | 2014 | 58 | 0.100 |
Why?
|
| Costs and Cost Analysis | 1 | 2012 | 40 | 0.090 |
Why?
|
| Cholesterol, LDL | 1 | 2012 | 64 | 0.090 |
Why?
|
| Glycated Hemoglobin A | 1 | 2012 | 64 | 0.090 |
Why?
|
| Blood Pressure | 1 | 2012 | 358 | 0.080 |
Why?
|
| United States | 4 | 2020 | 2247 | 0.080 |
Why?
|
| Insurance, Pharmaceutical Services | 1 | 2008 | 9 | 0.070 |
Why?
|
| Program Development | 1 | 2008 | 88 | 0.070 |
Why?
|
| Professional-Patient Relations | 1 | 2008 | 29 | 0.070 |
Why?
|
| Competency-Based Education | 1 | 2008 | 18 | 0.070 |
Why?
|
| Mobile Applications | 1 | 2026 | 81 | 0.060 |
Why?
|
| Florida | 1 | 2004 | 55 | 0.050 |
Why?
|
| Pharmacies | 1 | 2004 | 19 | 0.050 |
Why?
|
| Drug Prescriptions | 1 | 2004 | 46 | 0.050 |
Why?
|
| Ambulatory Care | 1 | 2004 | 63 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2026 | 413 | 0.050 |
Why?
|
| Referral and Consultation | 1 | 2024 | 98 | 0.050 |
Why?
|
| Health Personnel | 1 | 2024 | 99 | 0.050 |
Why?
|
| Mass Screening | 1 | 2024 | 159 | 0.050 |
Why?
|
| Confidence Intervals | 1 | 2002 | 69 | 0.050 |
Why?
|
| Telemedicine | 1 | 2026 | 214 | 0.050 |
Why?
|
| Chi-Square Distribution | 1 | 2002 | 145 | 0.050 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2002 | 100 | 0.050 |
Why?
|
| Odds Ratio | 1 | 2002 | 237 | 0.050 |
Why?
|
| Residence Characteristics | 1 | 2002 | 105 | 0.050 |
Why?
|
| Multivariate Analysis | 1 | 2002 | 303 | 0.050 |
Why?
|
| Logistic Models | 1 | 2002 | 415 | 0.040 |
Why?
|
| Sex Factors | 1 | 2002 | 470 | 0.040 |
Why?
|
| Canada | 1 | 2020 | 60 | 0.040 |
Why?
|
| Cultural Competency | 1 | 2020 | 18 | 0.040 |
Why?
|
| Oklahoma | 1 | 2024 | 1058 | 0.040 |
Why?
|
| Data Collection | 2 | 2008 | 109 | 0.030 |
Why?
|
| Risk Factors | 1 | 2002 | 2134 | 0.030 |
Why?
|
| Prescription Drugs | 1 | 2014 | 15 | 0.030 |
Why?
|
| Investments | 1 | 2008 | 1 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2008 | 116 | 0.020 |
Why?
|